Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

Thai HIV-1-infected women do not require a dose increase of lopinavir/ritonavir during the third trimester of pregnancy.

Ramautarsing RA, van der Lugt J, Gorowara M, Kerr SJ, Burger D, Ruxrungtham K, Phanuphak P, Chaithongwongwatthana S, Avihingsanon A, Phanuphak N.

AIDS. 2011 Jun 19;25(10):1299-303. doi: 10.1097/QAD.0b013e328347f7e9.

PMID:
21516029
2.

Safety and efficacy of lopinavir/ritonavir during pregnancy: a systematic review.

Pasley MV, Martinez M, Hermes A, d'Amico R, Nilius A.

AIDS Rev. 2013 Jan-Mar;15(1):38-48. Review.

PMID:
23449228
3.

Lopinavir/ritonavir: a protease inhibitor for HIV-1 treatment.

Barragan P, Podzamczer D.

Expert Opin Pharmacother. 2008 Sep;9(13):2363-75. doi: 10.1517/14656566.9.13.2363 . Review.

PMID:
18710360
4.

Genotypic resistance tests for the management of the HIV-infected pregnant woman.

Bassetti D, Cargnel A.

Scand J Infect Dis Suppl. 2003;106:70-4. Review.

PMID:
15000589
5.

Lopinavir/ritonavir in the treatment of human immunodeficiency virus infection.

Kaplan SS, Hicks CB.

Expert Opin Pharmacother. 2005 Aug;6(9):1573-85. Review.

PMID:
16086645
6.

HIV protease inhibitors in pregnancy : pharmacology and clinical use.

Andany N, Loutfy MR.

Drugs. 2013 Mar;73(3):229-47. doi: 10.1007/s40265-013-0017-3. Review.

PMID:
23404092
7.

The management of HIV-infected pregnant women.

Senise J, Bonafé S, Castelo A.

Curr Opin Obstet Gynecol. 2012 Dec;24(6):395-401. doi: 10.1097/GCO.0b013e328359f11e. Review.

PMID:
23160458

Supplemental Content

Support Center